MTOR and low grade glioma: Cacchione et al. [154] reported the clinical and radiological findings of a first-line treatment with everolimus, a selective mTOR inhibitor, in 10 patients that were diagnosed with mTOR-positive pediatric low-grade gliomas (pLGGs).